Christina Lake Cannabis Announces Filing of Audited Financial Statements
2024年6月18日 - 8:00PM
Christina Lake Cannabis Corp. ("CLC" or the
"Company") (CSE: CLC) is pleased to confirm that further to its
news releases dated April 3, 2024, April 17, 2024, May 1, 2024, May
15, 2024, May 29, 2024 and June 3, 2024, the Company has filed on
SEDAR its audited financial statements, accompanying management
discussion and analysis and related CEO and CFO certifications for
the year ended November 30, 2023 (the "Annual Filings"). The Annual
Filings can be obtained on the Company's SEDAR profile at
www.sedarplus.ca.
As a consequence of the Annual Filings, the
Company expects that the management cease trade order formerly
granted on April 3, 2024, by applicable securities regulatory
authorities, will be revoked and that directors and officers of the
Company will be permitted to trade securities of the Company.
The Company wants to thank all of those who
worked diligently in assisting with the finalization of the Annual
Filings.
The Company expects to file its interim
financial statements for the period ended February 28, 2024 by no
later than June 24, 2024 (the "Interim Filings").
ABOUT CLC
Christina Lake Cannabis is a licensed producer
of cannabis under the Cannabis Act. It has secured a standard
cultivation license and corresponding processing amendment from
Health Canada (March 2020 and August 2020, respectively) as well as
a research and development license (early 2020). Christina Lake
Cannabis’ facility consists of a 32-acre property, which includes
over 950,000 square feet of outdoor grow space, offices,
propagation and drying rooms, research facilities, and a facility
dedicated to processing and extraction. Christina Lake Cannabis
also owns a 99-acre plot of land adjoining its principal site. CLC
focuses its production on creating high quality extracts and
distillate for its B2B client base with proprietary strains
specifically developed for outdoor cultivation to enhance
extraction quality.
For more information about CLC, please visit:
www.christinalakecannabis.com
Jennifer SmithInvestor Relations and Media
Inquiriesinvestors@clcannabis.com 902-229-7265
Forward Looking Information and Risk
Factors
This news release contains statements and
information that may constitute "forward-looking information"
within the meaning of applicable securities legislation, including
statements identified by the use of words such as "will",
"expects", "positions", "believe", "potential" and similar words,
including negatives thereof, or other similar expressions
concerning matters that are not historical facts.
Such forward-looking information is not
representative of historical facts or information or current
condition, but instead represent only the Company's beliefs
regarding future events, plans or objectives, many of which, by
their nature, are inherently uncertain and outside of the Company's
control. Generally, such forward-looking information can be
identified by the use of forward-looking terminology such as
"plans", "expects" or "does not expect", "is expected", "budget",
"scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words
and phrases or may contain statements that certain actions, events
or results "may", "could", "would", "might" or "will be taken",
"will continue", "will occur" or "will be achieved". The
forward-looking information contained herein may include, but is
not limited to, information concerning the estimated filing date of
the Interim Filings.
By identifying such information and statements
in this manner, the Company is alerting the reader that such
information and statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
information and statements. Some of these risks include, but are
not limited to, the risk that the Interim Filings are filed later
than anticipated or at all, or the Company does not comply with the
provisions set out in NP 12-203, in which case there is a risk that
trading in the Company’s securities may halted and/or cease traded
temporarily by the Canadian securities commissions until such time
as the Interim Filings are filed on SEDAR.
Although the Company has attempted to identify
important factors that could cause actual results to differ
materially from those contained in the forward-looking information,
there may be other factors that cause results not to be as
anticipated, estimated or intended.
In connection with the forward-looking
information contained in this news release, the Company has made
certain assumptions. Although the Company believes that the
assumptions and factors used in preparing, and the expectations
contained in, the forward-looking information and statements are
reasonable, undue reliance should not be placed on such information
and statements, and no assurance or guarantee can be given that
such forward-looking information and statements will prove to be
accurate, as actual results and future events could differ
materially from those anticipated in such information and
statements. The forward-looking information contained in this news
release are made as of the date of this news release, and the
Company does not undertake to update any forward-looking
information and/or forward-looking statements that are contained or
referenced herein, except in accordance with applicable securities
laws. All subsequent written and oral forward-looking information
and statements attributable to the Company or persons acting on its
behalf are expressly qualified in their entirety by this
notice.
Core Laboratories (NYSE:CLB)
過去 株価チャート
から 12 2024 まで 1 2025
Core Laboratories (NYSE:CLB)
過去 株価チャート
から 1 2024 まで 1 2025